Julianna Svishchuk, BSc

Graduate Student
University of Calgary, Canada

Disclosure(s): No financial relationships to disclose

Julianna Svishchuk, BSc, is currently a graduate student in Dr. Michael Parkins research group at the University of Calgary in Alberta, Canada, in the Department of Microbiology, Immunology, and Infectious Diseases. Julianna began her work at the Parkins Lab in May of 2019 as an undergraduate student, looking at the impact of inoculum effects in methicillin-sensitive Staphyloccocus aureus in the context of cystic fibrosis lung infections. Her work has continued into her graduate degree, where she now investigates the role of cytomegalovirus in the CF lung. Julianna is honoured to be attending IDWeek 2022, and looks forward to persenting her work, as well as hearing about all the phenomenal research ongoing in the field of infectious diseases.

Poster(s):

• 511 - The cefazolin (CZ) and piperacillin-tazobactam (TZP) inoculum effects (IEs) are persistent amongst serial isolates of methicillin-sensitive Staphylococcus aureus (MSSA) derived from the sputum of persons with cystic fibrosis (pwCF) despite variation in other phenotypes.
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1813 - A Population-Based Multi-Year Assessment of the Incidence of High Inoculum Cefazolin (CZ) Resistance Amongst Methicillin-Susceptible Staphylococcus aureus (MSSA) Causing Bloodstream Infections (BSIs) over time in Calgary, Canada.
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET